Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 16638853)

1.

Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.

Romeo MJ, Wunderlich J, Ngo L, Rosenberg SA, Steinberg SM, Berman DM.

Clin Cancer Res. 2006 Apr 15;12(8):2463-7.

2.

RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.

Itakura E, Huang RR, Wen DR, Paul E, Wünsch PH, Cochran AJ.

Mod Pathol. 2008 Mar;21(3):326-33. doi: 10.1038/modpathol.3801008. Epub 2008 Jan 18.

3.

Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA.

Hofbauer GF, Dummer R, Laine E, Burg G.

Arch Dermatol Res. 1998 Aug;290(8):458-61. No abstract available.

PMID:
9763311
4.

Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.

Ringhoffer M, Schmitt M, Karbach J, Jäger E, Oesch F, Arand M.

Int J Oncol. 2001 Nov;19(5):983-9.

PMID:
11604998
5.

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.

Xu Y, Theobald V, Sung C, DePalma K, Atwater L, Seiger K, Perricone MA, Richards SM.

J Transl Med. 2008 Oct 22;6:61. doi: 10.1186/1479-5876-6-61.

7.

Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.

Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, Edwards MJ, Martin RC, Lewis AM, Stromberg AJ, Conrad AJ, Hagendoorn L, Albrecht J, McMasters KM.

J Clin Oncol. 2006 Jun 20;24(18):2849-57.

8.

Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens.

Perez RP, Zhang P, Bosserhoff AK, Buettner R, Abu-Hadid M.

Hum Pathol. 2000 Nov;31(11):1381-8.

PMID:
11112213
9.

Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction.

Keilholz U, Goldin-Lang P, Bechrakis NE, Max N, Letsch A, Schmittel A, Scheibenbogen C, Heufelder K, Eggermont A, Thiel E.

Clin Cancer Res. 2004 Mar 1;10(5):1605-12.

10.

Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.

Hasselmann DO, Rappl G, Rössler M, Ugurel S, Tilgen W, Reinhold U.

Oncol Rep. 2001 Jan-Feb;8(1):115-8.

PMID:
11115581
11.

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.

Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, Simonis TB, Duray PH, Herlyn M, Kawakami Y, Rosenberg SA.

J Immunother Emphasis Tumor Immunol. 1996 May;19(3):192-205.

PMID:
8811494
12.

Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.

Arenberger P, Arenbergerova M, Gkalpakiotis S, Lippert J, Stribrna J, Kremen J.

J Eur Acad Dermatol Venereol. 2008 Jan;22(1):56-64. doi: 10.1111/j.1468-3083.2007.02329.x.

PMID:
18181974
13.

What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?

Quaglino P, Osella-Abate S, Savoia P, Bernengo MG, Cappello N, Cavallo F.

J Clin Oncol. 2007 Mar 20;25(9):1140-1; author reply 1141-2. No abstract available.

14.

RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.

Samija M, Juretić A, Solarić M, Samija I, Bingulac-Popović J, Grahovac B, Stanec M, Oresić V.

Croat Med J. 2001 Aug;42(4):478-83.

15.

"Stealth" melanoma cells in histology-negative sentinel lymph nodes.

Itakura E, Huang RR, Wen DR, Cochran AJ.

Am J Surg Pathol. 2011 Nov;35(11):1657-65. doi: 10.1097/PAS.0b013e3182322cf7.

16.

Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases.

Mocellin S, Fetsch P, Abati A, Phan GQ, Wang E, Provenzano M, Stroncek D, Rosenberg SA, Marincola FM.

J Immunother. 2001 Nov-Dec;24(6):447-58.

PMID:
11759068
17.

Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.

Goto Y, Ferrone S, Arigami T, Kitago M, Tanemura A, Sunami E, Nguyen SL, Turner RR, Morton DL, Hoon DS.

Clin Cancer Res. 2008 Jun 1;14(11):3401-7. doi: 10.1158/1078-0432.CCR-07-1842.

18.

Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.

Włodzimierz R, Rutkowski P, Nowecki ZI, Kulik J, Nasierowska-Guttmejer A, Siedlecki JA.

Ann Surg Oncol. 2004 Nov;11(11):988-97. Epub 2004 Oct 15.

PMID:
15525828
19.

Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma.

Schmidt H, Sørensen BS, von der Maase H, Bang C, Agger R, Hokland M, Nexo E.

Melanoma Res. 2002 Dec;12(6):585-92.

PMID:
12459648
20.

Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.

Cormier JN, Abati A, Fetsch P, Hijazi YM, Rosenberg SA, Marincola FM, Topalian SL.

J Immunother. 1998 Jan;21(1):27-31.

PMID:
9456433
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk